Medical Marijuana, The Best Medicine For Migraines
Posted by Marijuana Doctors on 01/19/2016 in Medical Marijuana Studies
A recent study, proves that medical marijuana is a therapeutic treatment for migraines, and headaches. Researchers say that the study, “Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population – Pharmacotherapy, 2016” is the first of its kind, because the federal government does not permit any scientific research on Schedule 1 drugs, making it a near mission-impossible, for researchers to legally gain access to marijuana for scientific study. However, the latest study contains scientific evidence to substantiate what many sufferers have been claiming for years – cannabis has curative capability’s in treating headaches, and migraines.
Researches from the University of Colorado Anschutz Medical Campus, treated 121 participants diagnosed with migraines. Between January 2010 and September 2014, the patients treated with medical marijuana, found a reduction in migraine attack’s, from over 10 a month, down to less than 5 a month. 103 of the participant patients reported an overall decrease in attacks, while only 3 individuals reported an increase in migraine attacks, over the course of the trial.
Significant results, say the research team, who believe the findings may help to jumpstart medical marijuana as a migraine treatment, in states where medical marijuana laws are already in effect – or at the very least prompt more research of the subject.
Laura Borgelt, author of the study, and a professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences, explains that despite the findings, the team remain prudent in their research suggesting that cannabis is not a one-stop cure for all. “There was a substantial improvement for patients in their ability to function and feel better. Like any drug, marijuana has potential benefits and potential risks. It’s important for people to be aware that using medical marijuana can also have adverse effects,” Borglet said in a press release.
“We believe serotonin plays a role in migraine headaches, but we are still working to discover the exact role of cannabinoids in this condition,” Laura Borgelt said. However, more research is needed to fully determine exactly how, cannabis can be therapeutically beneficial.
More research requires the federal rescheduling of cannabis, currently listed as a Schedule 1 Controlled Substance, which is defined as a drug with no currently accepted medical use, and high potential for abuse. However, there is already significant scientific research and data proving the medical benefit of marijuana in treating patients with a wide variety of severe, debilitating or life threatening medical conditions, including cancer, HIV/AIDS, amyotrophic lateral sclerosis (ALS), neurodegenerative diseases like Parkinson’s disease, epilepsy and seizures, crohn’s disease and inflammatory bowel disease, mental health disorders such as PTSD, and chronic pain as the result of accident, injury, or illness.
The time has come for the federal government to give up the half-baked lie that marijuana is not medicinal. It is time for the federal government to hear the voices of the physicians, patients, and scientific researchers alike, and reschedule cannabis appropriately, allowing for maximum research, and pharmacological understanding.